Management of Acute Hyponatremia at 126 mmol/L
For acute hyponatremia at 126 mmol/L, immediately assess symptom severity and volume status to determine treatment urgency—if severe symptoms (seizures, altered mental status, coma) are present, administer 3% hypertonic saline targeting 6 mmol/L correction over 6 hours; if asymptomatic or mildly symptomatic, treatment depends on whether the patient is hypovolemic, euvolemic, or hypervolemic. 1
Immediate Assessment Required
Determine if symptoms are severe:
- Severe symptoms include seizures, coma, altered mental status, confusion, or cardiorespiratory distress 1, 2
- Mild symptoms include nausea, vomiting, headache, weakness, or mild cognitive changes 2, 3
- Even at 126 mmol/L, this represents moderate hyponatremia requiring intervention 1, 2
Assess volume status through physical examination:
- Hypovolemic signs: orthostatic hypotension, dry mucous membranes, decreased skin turgor, flat neck veins 1
- Euvolemic signs: normal blood pressure, no edema, normal skin turgor 1
- Hypervolemic signs: peripheral edema, ascites, jugular venous distention 1
Treatment Based on Symptom Severity
For Severe Symptomatic Hyponatremia (Medical Emergency)
Administer 3% hypertonic saline immediately:
- Give 100 mL bolus over 10 minutes, can repeat up to 3 times at 10-minute intervals until symptoms improve 1
- Target correction of 6 mmol/L over first 6 hours or until severe symptoms resolve 1, 2
- Critical safety limit: Never exceed 8 mmol/L correction in 24 hours to prevent osmotic demyelination syndrome 1, 3
Monitoring during acute correction:
- Check serum sodium every 2 hours during initial correction phase 1
- Once severe symptoms resolve, check every 4 hours 1
- ICU admission is recommended for close monitoring 1
For Asymptomatic or Mildly Symptomatic Hyponatremia
Treatment depends on volume status:
Hypovolemic hyponatremia (volume depletion):
- Discontinue diuretics immediately 1
- Administer isotonic saline (0.9% NaCl) for volume repletion 1, 2
- Initial infusion rate: 15-20 mL/kg/h, then 4-14 mL/kg/h based on response 1
- Urine sodium <30 mmol/L predicts good response to saline (71-100% positive predictive value) 1
Euvolemic hyponatremia (likely SIADH):
- Fluid restriction to 1 L/day is cornerstone of treatment 1, 2
- If no response to fluid restriction, add oral sodium chloride 100 mEq three times daily 1
- Consider vasopressin receptor antagonists (tolvaptan 15 mg daily) for resistant cases 1, 4
- Avoid hypotonic fluids which will worsen hyponatremia 1
Hypervolemic hyponatremia (heart failure, cirrhosis):
- Implement fluid restriction to 1-1.5 L/day 1, 2
- Discontinue diuretics temporarily if sodium <125 mmol/L 1
- For cirrhotic patients, consider albumin infusion alongside fluid restriction 1
- Avoid hypertonic saline unless life-threatening symptoms present, as it worsens edema and ascites 1
Critical Correction Rate Guidelines
Standard correction rates to prevent osmotic demyelination syndrome:
- Maximum 8 mmol/L in 24 hours for most patients 1, 3
- For high-risk patients (advanced liver disease, alcoholism, malnutrition, prior encephalopathy): limit to 4-6 mmol/L per day 1
- Acute hyponatremia (<48 hours) can be corrected more rapidly than chronic 1
- Chronic hyponatremia (>48 hours or unknown duration) requires slower correction 1, 5
Calculating Sodium Deficit
Use this formula to guide replacement:
- Sodium deficit = Desired increase in Na (mEq/L) × (0.5 × ideal body weight in kg) 1
- This helps determine appropriate volume of hypertonic saline needed 1
Common Pitfalls to Avoid
Never correct too rapidly:
- Overcorrection exceeding 8 mmol/L in 24 hours causes osmotic demyelination syndrome 1, 3
- Symptoms of osmotic demyelination (dysarthria, dysphagia, oculomotor dysfunction, quadriparesis) typically occur 2-7 days after rapid correction 1
If overcorrection occurs:
- Immediately discontinue current fluids and switch to D5W (5% dextrose in water) 1
- Consider administering desmopressin to slow or reverse rapid sodium rise 1
Do not use fluid restriction in certain situations:
- Never use fluid restriction in cerebral salt wasting—this worsens outcomes 1
- Avoid fluid restriction in subarachnoid hemorrhage patients at risk of vasospasm 1
Distinguish SIADH from cerebral salt wasting in neurosurgical patients:
- SIADH: euvolemic, treat with fluid restriction 1
- Cerebral salt wasting: hypovolemic, treat with volume and sodium replacement 1
- Using wrong treatment approach can be harmful 1
Special Populations
Patients with cirrhosis:
- Require more cautious correction (4-6 mmol/L per day maximum) 1
- Hyponatremia increases risk of spontaneous bacterial peritonitis (OR 3.40), hepatorenal syndrome (OR 3.45), and hepatic encephalopathy (OR 2.36) 1
- Tolvaptan carries higher risk of gastrointestinal bleeding in cirrhosis (10% vs 2% placebo) 4
Patients with advanced liver disease, alcoholism, or malnutrition: